| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,356,820 | 1,378,462 | 1,379,584 | 1,552,589 | | Cost of Revenue | 704,651 | 674,251 | 660,007 | 736,580 | | | Gross Profit | 652,169 | 704,211 | 719,577 | 816,009 | | | Operating Expenses | | Research Development | 45,052 | 46,622 | 46,949 | 49,444 | | Selling General and Administrative | 449,617 | 424,265 | 443,528 | 475,375 | | Non Recurring | 12,845 |
-
|
-
| 115,117 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 144,655 | 233,324 | 229,100 | 176,073 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 668 | 933 | 1,552 | 12,893 | | Earnings Before Interest And Taxes | 145,323 | 234,257 | 230,652 | 188,966 | | Interest Expense | (22,646) | 54,991 | 52,203 | 61,879 | | Income Before Tax | 167,969 | 179,266 | 178,449 | 127,087 | | Income Tax Expense | 57,691 | 62,535 | 72,149 | 29,540 | | Minority Interest | (13,714) |
-
|
-
| (4,621) | | | | Net Income From Continuing Ops | 110,278 | 116,731 | 106,300 | 92,926 | | | Non-recurring Events | | Discontinued Operations | (2,429) | 5,102 | 2,623 | (18,974) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 94,135 | 121,833 | 108,923 | 73,952 | | Preferred Stock And Other Adjustments | 9,092 | (4,571) | (4,521) |
-
| | | Net Income Applicable To Common Shares | $103,227 | $117,262 | $104,402 | $73,952 |
|
0.11% Nasdaq 
0.01%
Income Statement
